Preferred Label : mitotane;
MeSH definition : A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits
cells of the adrenal cortex and their production of hormones. It is used to treat
adrenocortical tumors and causes CNS damage, but no bone marrow depression.;
MeSH synonym : o,p-ddd; ortho,para ddd; ortho,para-ddd; mytotan;
CISMeF synonym : Bristol-Myers squibb brand of mitotane; bristol myers squibb brand of mitotane;
MeSH hyponym : chlodithane; chloditan; lysodren; Khloditan;
MeSH CAS label : benzene, 1-chloro-2-(2,2-dichloro-1-(4-chlorophenyl)ethyl)-;
MeSH Related Number : 53-19-0 (Mitotane);
Registry Number MeSH : 53-19-0;
MeSH annotation : TN 111 for eff on insects;
Wikipedia link : https://en.wikipedia.org/wiki/Mitotane;
Codes EINECS : 200-166-6;
Is substance : O;
UNII : 78E4J5IB5J;
InChIKey : JWBOIMRXGHLCPP-UHFFFAOYSA-N;
Origin ID : D008939;
UMLS CUI : C0026256;
ATC code(s)
Allowable qualifiers
CISMeF manual mappings
Currated CISMeF NLP mapping
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits
cells of the adrenal cortex and their production of hormones. It is used to treat
adrenocortical tumors and causes CNS damage, but no bone marrow depression.
http://www.sfendocrino.org/_images/mediatheque/articles/pdf/INCA%20Comete/2014%20thesaurus_corticosurrenalome_2014.pdf
2014
false
false
false
France
French
adrenal cortex neoplasms
adult
practice guideline
adrenal cortex neoplasms
adrenal cortex neoplasms
neoplasm recurrence, local
adrenal cortex neoplasms
mitotane
antineoplastic agents, hormonal
algorithms
---
https://www.ema.europa.eu/medicines/human/EPAR/Lysodren
2012
United Kingdom
French
English
syndication feed
antineoplastic agents, hormonal
mitotane
antineoplastic agents, hormonal
breast feeding
orphan drug production
tablets
administration, oral
drug evaluation
treatment outcome
drug approval
drug labeling
adrenocortical carcinoma
mitotane
adult
child
drug interactions
pregnancy
mitotane
package leaflet
summary of product characteristics
drug evaluation
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct031673.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_400100
2004
France
French
evaluation of the transparency committee
mitotane
antineoplastic agents, hormonal
administration, oral
orphan drug production
mitotane
adrenal cortex neoplasms
adult
child
aged
treatment outcome
---